A Multi Centre, Open Label, Non-Randomized, Non Interventional, Observational Study on the Safety and Efficacy of Biphasic Insulin Aspart (NovoMix 30, NovoMix 50 and NovoMix 70 or Combinations) in Type 2 Diabetes Mellitus Patients.
Phase of Trial: Phase III
Latest Information Update: 02 Nov 2016
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 06 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Feb 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.